The FDA may give drug manufacturer Purdue Pharma a six-month extension of its original OxyContin patent as an incentive for the completed pediatric study.
Related Articles on Pain Management:
Study: Hospitals Struggle With Pediatric Pain
Pain Management Physician Joins Coastal Orthopedics
Report: Florida Closed Half of Pain Management Clinics in Two Years
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
